I agree. But why the SP still struggling to get over $170. Investors hate uncertainty which is the performance of the infant formula business. This is clearly a $190 stock. A2 and BAL have nearly hit their February highs but BKL is still languishing. Look at BHP, massive writedowns but provided investors with certainty about where the business is headed.